What clinical studies were used to support mifepristone approval?
Mifepristone (a progesterone receptor antagonist) has been studied in multiple clinical trial programs for different indications. The specific studies and outcomes depend on the use case (for example, medical abortion vs. other approved indications), and approval decisions typically rely on evidence showing effectiveness, safety, and an acceptable risk–benefit profile across relevant patient groups.
What do mifepristone clinical trials measure (and what endpoints matter most)?
Across mifepristone studies, trials generally track endpoints tied to the indication, such as:
- Effectiveness outcomes (for example, completion of the intended clinical event without additional intervention where that is the goal of the regimen).
- Safety outcomes (including rates of serious adverse events and clinically important complications).
- Acceptability and feasibility outcomes (such as follow-up completion and need for additional care).
How do abortion-related mifepristone studies typically differ by regimen?
When mifepristone is studied for medical abortion, clinical trials commonly evaluate it as part of a regimen that may include an additional medication (the second agent and dosing schedule can vary by protocol). Studies also differ by:
- Gestational age range studied
- Comparison strategy (single-arm vs. randomized comparisons)
- Follow-up schedule (how quickly outcomes are assessed and what “success” means operationally)
Who participates in mifepristone studies?
Mifepristone trials typically include clearly defined eligibility criteria, which may cover factors such as gestational age (for abortion indications), medical history, concurrent medications, and risk factors for complications. Study populations are selected to ensure investigators can interpret outcomes and safety signals for the intended use setting.
What side effects do mifepristone studies report most often?
Mifepristone clinical trial publications generally report both short-term and clinically significant adverse events relevant to the indication, which can include:
- Expected, regimen-related symptoms (such as bleeding and cramping when studied for abortion-related indications)
- Less common but important complications (captured as adverse events and serious adverse events depending on severity and frequency)
How do researchers handle safety monitoring in mifepristone trials?
Clinical studies for mifepristone include safety monitoring through predefined adverse event collection and escalation pathways. Trials often specify:
- What events count as serious adverse events
- How participants are followed after treatment
- When study teams intervene or recommend additional care
How long do mifepristone studies follow patients after treatment?
Follow-up time varies by protocol and indication. Trials typically include an early assessment window to determine initial outcome (such as completion vs. ongoing condition) and may also include later follow-up to capture delayed complications and confirm sustained success.
Are there studies comparing mifepristone to alternatives?
For abortion-related indications, clinical research often compares mifepristone-based regimens against other medication protocols and/or against procedural options, depending on the trial. For non-abortion indications, studies may compare mifepristone-containing approaches against standard care. Exact comparisons depend on the specific indication and approval pathway.
Where can you find the main mifepristone clinical study reports?
The best source is the peer-reviewed clinical trial literature for each indication plus regulatory review documents tied to the approval history. If you tell me which indication you mean (for example, medical abortion vs. another approved use), I can narrow to the most relevant clinical trial types and the specific outcomes commonly reported for that indication.
Sources
No source links were provided in your prompt, so I can’t accurately cite specific mifepristone clinical studies or trial publications yet. If you share the indication or paste links/titles you’re looking at, I can synthesize those specific studies with citations.